On Sept. 27, the U.S. Department of Justice announced criminal charges against 35 individuals across various jurisdictions, allegedly involved in genetic testing fraud schemes that cost taxpayers over $2.1 billion.
On October 28, 2019, the Third Circuit became the most
recent circuit court to determine that the False Claims Act’s (“FCA”) other
alternate-remedy provision, 31 U.S.C. § 3730(c)(5), does not give a relator the
right to intervene in a criminal proceeding. United States v.
The United States recently filed a False Claims Act Complaint in Intervention against Florida-based compounding pharmacy Patient Care America (“PCA”), two PCA employees, as well as the private equity (“PE”) firm that acquired PCA and helped manage the company.
On September 18, 2019, the Department of Justice announced a $21.35 million settlement with compounding pharmacy Patient Care America, PCA executives Patrick Smith and Matthew Smith, and, most notably, the pharmacy’s private equity backer, Riordan, Lewis & Haden Inc. The private equity firm and the pharmacy will fund substantially all of the settlement ($21.036 million).
The Third Circuit ruled on September 12, 2019 that a relator
is not automatically guaranteed a hearing when the government moves to dismiss
a whistleblower action – they need to ask for one. In United States ex rel., Chang v.
Children’s Advocacy Center of Delaware,
No.
What Happened
On July 1, 2019, The Treasury Laws Amendment (Enhancing
Whistleblower Protections) Bill 2019 (“Bill 19”) came into effect that amended
the Corporations Act 2001 and Taxation Administration Act 1953 to provide more
protections for whistleblowers in Australia.
On July 16, 2019, a
district court in California found that not all information that is posted on
the internet is considered a public disclosure by the “news media.” United States ex rel. Integra Med Analytics Llc
v. Providence Health & Servs.,
No.
What Happened
On July 1, 2016, the Dutch Whistleblowers Act (Wet Huis voor klokkenluiders, “Whistleblowers
Act”) came into effect, requiring all employers
in the Netherlands with 50 employees or more to implement internal reporting
procedures and ban retaliatory acts against employees who report wrongdoing.
As seen on the EU blog, LawHealthTech.com:
Member States of the European Union, over the last several years, have passed a series of so-called “Whistleblower Laws.” These laws are being implemented allegedly to bolster anti-corruption efforts throughout Europe.
On May 13, 2019, the Supreme Court of the United States, in
a unanimous decision, delivered an important victory for qui tam whistleblowers. United States ex rel. Hunt v. Cochise Consultancy,
Inc., No. 18-315 (decided May 13, 2019) (referred to as “Hunt”).